Similar articles

• Cytomegalovirus infection in transplant patients.

  Betts RF. Betts RF. Prog Med Virol. 1982;28:44-64. Prog Med Virol. 1982. PMID: 6283602 Review. No abstract available.
• Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients.

  Volpi A, Pica F, Gentile G, Capobianchi A, Fraschetti M, Martino P. Volpi A, et al. J Infect Dis. 1999 Nov;180(5):1747-8. doi: 10.1086/315092. J Infect Dis. 1999. PMID: 10515847 No abstract available.
• Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients.

  Emanuel D. Emanuel D. Monogr Allergy. 1988;23:216-24. Monogr Allergy. 1988. PMID: 2838745 No abstract available.
• Cell-mediated immunity to cytomegalovirus in mice and in renal transplant recipients.

  Howard RJ, Balfour HH Jr. Howard RJ, et al. Transplant Proc. 1979 Mar;11(1):75-8. Transplant Proc. 1979. PMID: 222021 No abstract available.
• Therapeutic approaches to the control of cytomegalovirus infections.

  Dworsky M, Pass RF, Stagno S, Whitley RJ. Dworsky M, et al. Birth Defects Orig Artic Ser. 1984;20(1):345-52. Birth Defects Orig Artic Ser. 1984. PMID: 6329371 Review. No abstract available.